Benedicte Stavik Selected Research

Coagulants

1/2016

EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benedicte Stavik Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 08/2022 - 11/2010
12	Neoplasms (Cancer) 08/2022 - 11/2010
5	Thrombosis (Thrombus) 01/2023 - 07/2017
3	Inflammation (Inflammations) 11/2022 - 01/2017
2	Hemorrhage 01/2023 - 12/2021
2	Hypoxia (Hypoxemia) 09/2017 - 01/2016
2	Atherosclerotic Plaque (Atheroma) 07/2017 - 01/2016
2	Neoplasm Metastasis (Metastasis) 08/2011 - 11/2010
2	Obesity 04/2011 - 01/2010
2	Weight Gain 04/2011 - 01/2010
1	Intestinal Failure 03/2024
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Thrombophilia 01/2023
1	Inherited Blood Coagulation Disorders 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Stroke (Strokes) 11/2022
1	Herpes Zoster 11/2022
1	Wounds and Injuries (Trauma) 11/2022
1	Sepsis (Septicemia) 11/2022
1	Disease Progression 01/2020
1	Ischemic Stroke 07/2017
1	Carotid Artery Diseases 07/2017
1	Carotid Stenosis (Carotid Artery Stenosis) 07/2017
1	Type 2 Diabetes Mellitus (MODY) 10/2016
1	Atherosclerosis 01/2016
1	Body Weight (Weight, Body) 04/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2010

Drug/Important Bio-Agent (IBA)

14	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2023 - 06/2010
7	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
4	Thromboplastin (Tissue Factor)IBA 09/2017 - 08/2011
4	Hormones (Hormone)IBA 01/2017 - 01/2010
3	Protein Isoforms (Isoforms)IBA 01/2013 - 08/2011
2	Thrombin FDA Link 01/2023 - 01/2016
2	Factor VII (Proconvertin)IBA 11/2022 - 12/2021
2	Estrogen ReceptorsIBA 08/2022 - 01/2017
2	Hemostatics (Antihemorrhagics)IBA 08/2022 - 08/2011
2	Factor V (Coagulation Factor V)IBA 08/2022 - 01/2020
2	Estrogens (Estrogen)FDA Link 08/2022 - 01/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 08/2022 - 09/2017
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2020 - 01/2017
2	Oxygen (Dioxygen)IBA 09/2017 - 01/2016
2	CytokinesIBA 01/2017 - 10/2016
2	Insulin (Novolin)FDA Link 10/2016 - 04/2011
1	VaccinesIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	DNA VaccinesIBA 01/2023
1	Histones (Histone)IBA 11/2022
1	Peptide Hydrolases (Proteases)FDA Link 11/2022
1	cadherin 5IBA 11/2022
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2016
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2016
1	LipidsIBA 01/2016
1	CoagulantsIBA 01/2016
1	Syndecan-3IBA 01/2015
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 07/2014
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2013
1	Heparin (Liquaemin)FDA LinkGeneric 01/2013
1	Complementary DNA (cDNA)IBA 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2012
1	Tyrosine (L-Tyrosine)FDA Link 08/2011
1	Endocrine DisruptorsIBA 04/2011
1	Death Domain ReceptorsIBA 11/2010
1	Persistent Organic PollutantsIBA 01/2010
1	SteroidsIBA 01/2010

Therapy/Procedure

1	Parenteral Nutrition 03/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Carotid Endarterectomy 07/2017